Pay-For-Delay Deals Can Be Illegal, Justices Rule

The U.S. Supreme Court on Monday ruled that patent law doesn't shield so-called pay-for-delay deals from antitrust scrutiny, paving the way for the Federal Trade Commission to target pharmaceutical companies over...

Already a subscriber? Click here to view full article